3-n-methylspiperone has been researched along with Movement Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batshaw, ML; Dannals, RF; Harris, JC; Links, JM; Moser, HW; Naidu, S; Rett, A; Wagner, HN; Wong, DF | 1 |
| Wagner, HN | 1 |
2 other study(ies) available for 3-n-methylspiperone and Movement Disorders
| Article | Year |
|---|---|
Positron emission tomographic study of D2 dopamine receptor binding and CSF biogenic amine metabolites in Rett syndrome.
Topics: Adult; Binding Sites; Biogenic Amines; Brain; Chromatography, High Pressure Liquid; Female; Humans; Intellectual Disability; Movement Disorders; Receptors, Dopamine; Spiperone; Syndrome; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1986 |
Rett syndrome: positron emission tomography (PET) studies.
Topics: Adult; Age Factors; Aged; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Intellectual Disability; Male; Middle Aged; Movement Disorders; Receptors, Dopamine; Spiperone; Syndrome; Time Factors; Tomography, Emission-Computed | 1986 |